Evidence map›Paper›PMID 41806028›Full record

ReviewArchives of microbiology2026

Alternative approaches in combating antimicrobial resistance in animals.

Rafał Nejfeld, Dorota Chrobak-Chmiel, Ewelina Kwiecień, Ilona Stefańska, Krystyna Mordzińska, Magdalena Rzewuska, Małgorzata Gieryńska

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rafał NejfeldDepartment of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland. rafal_nejfeld@sggw.edu.pl.
Dorota Chrobak-ChmielDepartment of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland.
Ewelina KwiecieńDepartment of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland.
Ilona StefańskaDepartment of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland.
Krystyna MordzińskaFaculty of Biology and Biotechnology, Warsaw University of Life Sciences, Nowoursynowska 159, Warsaw, 02-776, Poland.
Magdalena RzewuskaDepartment of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland.
Małgorzata GieryńskaDepartment of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Ciszewskiego 8, Warsaw, 02-786, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing bacterial antimicrobial resistance is one of the most serious global challenges, undermining the effectiveness of conventional antibiotics and increasing morbidity and mortality across human and animal populations. Within the One Health framework, which emphasizes the interconnectedness of human, animal, and environmental health, interdisciplinary strategies are crucial for addressing this threat. Despite ongoing efforts, current approaches have not slowed the spread of resistant pathogens, underscoring a critical gap in the development of alternative therapeutics. This review addresses this gap by examining three promising strategies: phytotherapy (plant-derived antimicrobials), phage therapy (bacteriophage-based bacterial targeting), and antimicrobial peptides (membrane-disrupting bioactive molecules). These innovative approaches may serve as alternatives or adjuncts to traditional antimicrobials and are highly relevant to One Health applications. Emphasis is placed on their mechanisms of action, therapeutic efficacy, recent advances, and the challenges they pose for research.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesBacteriaBacterial InfectionsDrug Resistance, BacterialPhage TherapyPhytotherapyAnimalsBacteriophagesHumansOne HealthAnti-Bacterial AgentsAntimicrobial PeptidesAntimicrobial peptidesAntimicrobial resistanceOne HealthPhage therapyPhytotherapy

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.